Comprehensive preclinical pharmacology and pharmacodynamics evaluation bench & full range of animal models
KCI Biotech is a leading metabolism-focused preclinical CRO providing comprehensive research solutions for metabolic and endocrinology disorders. We specialize in developing and validating animal models of metabolic diseases that accurately mimic human pathophysiology.
Our metabolic CRO services support pharmaceutical and biotechnology clients in drug discovery, mechanism exploration, and efficacy evaluation across a wide range of metabolic indications. Each study is conducted under GLP-compliant conditions, ensuring data quality, reproducibility, and scientific integrity throughout every project stage.
Animal models play a vital role in understanding the pathogenesis and progression of metabolic diseases such as obesity, diabetes, and NASH. Since these disorders involve complex interactions among genetic, dietary, and environmental factors, in vivo metabolic disease models allow researchers to simulate human metabolic processes under controlled conditions. Validated models help preclinical CROs evaluate drug efficacy and safety with translational relevance before clinical trials.
KCI Biotech has developed a validated suite of animal models for metabolic disease, supporting comprehensive preclinical evaluation of novel therapeutics. Built under GLP-compliant standards, these preclinical metabolic models simulate key pathological mechanisms such as insulin resistance, lipid accumulation, fibrosis, and inflammatory injury.
Our metabolic disease models encompass diet-induced, chemically induced, and genetic systems that cover major indications such as obesity, diabetes and its complications, hyperlipidemia, NASH, acute liver injury, and liver fibrosis. These models enable mechanism-driven exploration and efficacy validation in both in vivo metabolic disease CRO and translational research settings.
Through this integrated metabolic CRO service platform, KCI Biotech provides reliable and reproducible data to accelerate drug discovery and development in metabolic and endocrine disorders.
KCI Biotech’s metabolic CRO services encompass the entire preclinical research cycle — from study planning to final reporting. Our workflow includes:
Consultation & Study Design — Literature review, project discussion, and customized protocol development.
Documentation & Contract — CDA, quotation, and project agreement.
Execution — Animal procurement, model establishment, dosing, and data collection.
Quality Assurance — GLP documentation, raw data verification, and audit trail.
Reporting & Archiving — Draft report, review, final report delivery, and secure data storage.
With every study, KCI Biotech strives to advance the understanding of metabolism-related diseases while providing dependable research support to global pharmaceutical innovators.
As a trusted metabolic diseases CRO, KCI Biotech offers integrated preclinical metabolic models and cutting-edge analytical capabilities to accelerate your metabolic and endocrinology drug development.
Partner with us to transform discovery into therapeutic success. For more information about our metabolic CRO services, please contact us today.
Comprehensive preclinical drug development and service platform
Building A2, No, 8 Yanghua road, Suzhou industrial Park, Suzhou.P.R, china
